ILC2-derived cytokines (IL-5 and IL-13) are therefore vital components controlling the progression of atherosclerosis, particularly IL-13 which may alter macrophage phenotype, and its absence leads to larger and potentially more vulnerable plaques. This evidence concerns the gene IL5 and atherosclerosis.